The official blog of the Lung Institute.

Relationship Between Diabetes and Lung Disease

4 Apr 2015
| Under COPD, Lung Disease | Posted by | 0 Comments
Diabetes and Lung Disease Lung Institute

Diabetes mellitus is an umbrella term for a group of diseases that affects blood sugar, also known as blood glucose, throughout the body. People with diabetes suffer from high amounts of glucose in the blood, which can lead to numerous health complications and unwanted symptoms. Diabetes patients, especially those with type 1 diabetes, have an immune system that responds poorly to fighting infections. This includes fighting lung diseases.

Diabetes and Lung Disease

As a result of a poorly functioning immune system, people with diabetes are more likely to catch a cold, flu or other illness that will likely require a longer period of time to recover. This can have a significant impact on blood sugar levels and the overall quality of an individual’s health. In fact, several lung diseases can affect diabetes and vice versa.

Diabetes can contribute to the development of pneumonia, tuberculosis and chronic obstructive pulmonary disease (COPD). Pneumonia is caused by an infection and consequential inflammation which puts pressure on the lungs and makes it hard to breath. The most common form of pneumonia is caused by a bacterial infection, named Streptococcus pneumonia. Despite popular belief, pneumonia is not caught because of cold weather. When diabetes goes untreated, it can lead to the occurrence of severe breathing difficulties in extreme temperatures associated with pneumonia.

Tuberculosis is caused by a bacterial infection and is very contagious. However, not everyone who gets infected with the bacteria develops tuberculosis. For those of us in the US, tuberculosis is fairly rare, although cases have been steadily increasing in recent years. The infection destroys the cells it comes in contact with, and this often happens in the lungs. Diabetes and pulmonary tuberculosis can greatly reduce the lung function of an individual.

One of the most general causes of COPD is smoking. Recently, studies have been produced suggesting that those suffering from diabetes can also have trouble breathing. If you combine this with the effect of smoking on the lungs, then the elasticity can become severely reduced. It is this combination that makes smoking so dangerous for diabetics. If you suffer from diabetes or COPD, it is recommended that you talk with your physician immediately about doing a lung function test.

If you or a loved one is interested in learning more about how stem cells may help treat lung disease, the Lung Institute can help. Contact a patient coordinator at (800) 729-3065 to find out if this treatment could help you breathe easier.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.